Adverse Event Reporting
| VAERS ID | 1430442 |
|---|---|
| Gender | Unknown |
| Age | |
| StateCode | CA |
| Pharmaceutical Company | JANSSEN |
| Lot Number | 204A21A |
| Number of vaccinations | 1 |
| Vaccinated | |
| Onset | |
| Condition | Hospitalized Life Threatening Permanent Disability |
Symptoms
- Intensive care
- Dysphagia
- Laboratory test
- Muscular weakness
- Computerised tomogram
- Magnetic resonance imaging
- Loss of personal independence in daily activities
- X-ray
- Blood potassium increased
- Endotracheal intubation
- Mechanical ventilation
- Haemodialysis
- Hyperkalaemia
- Hypotonia
- Respiratory failure
- Blood creatine phosphokinase increased
- Renal failure
- Diplegia
- Rhabdomyolysis
- Muscle injury
- Myoglobin blood increased
- Medical induction of coma
- Anuria
- Tracheostomy
Current Illness
Preexisting Conditions
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Extensive imaging including multiple MRIs, CTs, and numerous X-rays.
Extensive laboratory tests during 26 day hospital course.
Chart available upon request.
Write-up
Severe rhabdomyolysis with peak CK ~750,000, myoglobin >5000.
Severe life-threatening hyperkalemia, K up to ~7.
5.
Renal failure including ~2+ weeks anuria, still on hemodialysis 5 weeks post onset with uncertain prognosis.
Respiratory (muscle) failure, on ventilator for ~18 days with endotracheal tube, followed by tracheostomy ~1 week.
Hospitalized for 26 days including 19 days in Intensive Care Unit, ~11 days in medically induced coma.
Loss of swallowing function requiring retraining.
Profound diffuse muscle damage and weakness, ~20 lb.
loss of muscle mass, initially unable to move arms, legs or support head.
Will require extensive physical therapy to achieve ability to care for self and function somewhat independently.